Work

Results of a multicenter, randomized, double‐blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.24686

Authors: Tim Eisen, Uwe Trefzer, Anne Hamilton, Peter Hersey, Michael Millward, Robert D. Knight, Jarl U. Jungnelius, John Glaspy

Institutions: Royal Marsden Hospital, Charité – Universitätsmedizin Berlin, Royal Prince Alfred Hospital, Calvary Mater Newcastle Hospital, Celgene (United States), University of California, Los Angeles, Ronald Reagan UCLA Medical Center, UCLA Medical Center

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2080826905

FWCI: 3.493

Cites: 29

Cited by: 50

Related to: 10